Retirement Systems of Alabama Grows Stock Position in Avantor, Inc. (NYSE:AVTR)

Retirement Systems of Alabama lifted its stake in Avantor, Inc. (NYSE:AVTRFree Report) by 0.2% during the fourth quarter, Holdings Channel reports. The institutional investor owned 827,569 shares of the company’s stock after acquiring an additional 1,727 shares during the quarter. Retirement Systems of Alabama’s holdings in Avantor were worth $17,437,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. MassMutual Private Wealth & Trust FSB lifted its holdings in Avantor by 99.5% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,253 shares of the company’s stock valued at $26,000 after acquiring an additional 625 shares during the period. UMB Bank n.a. purchased a new position in shares of Avantor during the 3rd quarter valued at approximately $49,000. Nisa Investment Advisors LLC lifted its stake in shares of Avantor by 69.6% in the 3rd quarter. Nisa Investment Advisors LLC now owns 2,035 shares of the company’s stock valued at $53,000 after purchasing an additional 835 shares during the period. GAMMA Investing LLC boosted its holdings in Avantor by 89.9% during the third quarter. GAMMA Investing LLC now owns 2,715 shares of the company’s stock worth $70,000 after buying an additional 1,285 shares in the last quarter. Finally, Livforsakringsbolaget Skandia Omsesidigt grew its position in Avantor by 278.0% during the third quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 5,031 shares of the company’s stock valued at $130,000 after buying an additional 3,700 shares during the period. 95.08% of the stock is owned by institutional investors and hedge funds.

Avantor Price Performance

Shares of NYSE AVTR opened at $21.80 on Friday. The stock has a market capitalization of $14.83 billion, a price-to-earnings ratio of 47.38, a price-to-earnings-growth ratio of 3.97 and a beta of 1.28. Avantor, Inc. has a 52 week low of $19.59 and a 52 week high of $28.00. The firm has a 50-day simple moving average of $21.75 and a 200-day simple moving average of $23.47. The company has a quick ratio of 1.06, a current ratio of 1.54 and a debt-to-equity ratio of 0.84.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on AVTR. Barclays upped their price objective on shares of Avantor from $25.00 to $26.00 and gave the stock an “overweight” rating in a research report on Monday. Robert W. Baird lowered their price target on Avantor from $27.00 to $26.00 and set an “outperform” rating on the stock in a research report on Monday, October 28th. UBS Group restated a “neutral” rating and issued a $25.00 price objective (down from $29.00) on shares of Avantor in a research report on Friday, January 17th. Raymond James decreased their target price on Avantor from $29.00 to $26.00 and set an “outperform” rating on the stock in a research report on Tuesday, January 21st. Finally, Wells Fargo & Company cut their price target on shares of Avantor from $30.00 to $28.00 and set an “overweight” rating for the company in a report on Monday, October 28th. Three investment analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $27.46.

View Our Latest Stock Analysis on AVTR

Avantor Company Profile

(Free Report)

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.

Recommended Stories

Want to see what other hedge funds are holding AVTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avantor, Inc. (NYSE:AVTRFree Report).

Institutional Ownership by Quarter for Avantor (NYSE:AVTR)

Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.